HBF achieved a net positive result in the previous financial year, despite declining investment returns contributing to a more than halving of its year-on-year profitability.
Despite having just four years of experience in medicine, Chris Brennan-Jones has won plaudits pioneering affordable and accessible treatment for childhood ear disease.
The Women and Infants Research Foundation is a world leader in the field of early preterm birth and its chief scientific director, Professor John Newnham, has been a key driver in its success.
A common gout drug may prevent the progression of coronary disease, new research from Harry Perkins Institute of Medical Research and GenesisCare has found.
WA-based chemo@home and aged care services provider Silver Chain are creating a joint venture to ensure more patients can access chemotherapy treatments at home.
Perth-based HealthEngine has been ordered to pay $2.9 million in penalties by the Federal Court. It comes after the tech company achieved rapid growth but incurred big financial losses.
The Perth Children’s Hospital Foundation and Telethon Kids Institute have committed $10 million in fundraising over five years to support a new respiratory research centre.
Four builders including Multiplex and Lendlease have been shortlisted to complete major works under the $257 million expansion of Joondalup Health Campus, which will include new beds and operating theatres.
A $10.8 million liver cancer research centre has been established with donations from several philanthropic and research organisations, including $5 million from the Cancer Research Trust.
Contractor Georgiou Group will build a $25 million pipeline for the long-term supply of water into Denmark, while ADCO Constructions has secured an $8.8 million contract for early redevelopment works at the Geraldton Health Campus.
Upgrades to the emergency department at Peel Health Campus will resume later this month, with the works awarded to Canning Vale-based contractor Devlyn Construction.
In the midst of crucial contract negotiations with the state government, St John Ambulance WA chief executive Michelle Fyfe spoke to Business News about the group’s diversification strategy, lessons learned from COVID-19, and her career.
Invex Therapeutics has received a $5 million investment from Andrew Forrest’s Tattarang as part of a share placement, with the proceeds to go towards the company’s research into neurological diseases.
The state government has said it will allow public and private hospitals to increase elective surgeries to 50 per cent of normal activity as of Monday, following new guidelines set today by the national cabinet.
Few businesses in Western Australia have felt the impact of the COVID-19 pandemic in the way that Brightwater Care Group has, with aged care being challenged like almost no other sector while other income streams for the organisation have been severely curtailed.
